TY - JOUR AU - Malmberg, K. -. J. AU - Carlsten, M. AU - Björklund, A. AU - Sohlberg, E. AU - Bryceson, Y. T. AU - Ljunggren, H. -. G. PY - 2017 DA - 2017// TI - Natural killer cell-mediated immunosurveillance of human cancer JO - Semin Immunol VL - 31 UR - https://doi.org/10.1016/j.smim.2017.08.002 DO - 10.1016/j.smim.2017.08.002 ID - Malmberg2017 ER - TY - STD TI - Golstein P, Griffiths GM. An early history of T cell-mediated cytotoxicity. Nat Rev Immunol. 2018;18(8):527–35. ID - ref2 ER - TY - JOUR AU - Melero, I. AU - Rouzaut, A. AU - Motz, G. T. AU - Coukos, G. PY - 2014 DA - 2014// TI - T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious Cancer immunotherapy JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0985 DO - 10.1158/2159-8290.CD-13-0985 ID - Melero2014 ER - TY - JOUR AU - Sharma, P. AU - Allison, J. P. PY - 2015 DA - 2015// TI - The future of immune checkpoint therapy JO - Science. VL - 348 UR - https://doi.org/10.1126/science.aaa8172 DO - 10.1126/science.aaa8172 ID - Sharma2015 ER - TY - JOUR AU - Pitt, J. M. AU - Vétizou, M. AU - Daillère, R. AU - Roberti, M. P. AU - Yamazaki, T. AU - Routy, B. PY - 2016 DA - 2016// TI - Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors JO - Immunity. VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.06.001 DO - 10.1016/j.immuni.2016.06.001 ID - Pitt2016 ER - TY - STD TI - Puzzoni M, Silvestris N, Leone F, Giampieri R, Faloppi L, Demurtas L, et al. The immune revolution in gastrointestinal Tumours: leading the way or just following? Target Oncol. 2016;11(5):593–603. ID - ref6 ER - TY - JOUR AU - Zhao, X. AU - Subramanian, S. PY - 2017 DA - 2017// TI - Intrinsic resistance of solid tumors to immune checkpoint blockade therapy JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-2379 DO - 10.1158/0008-5472.CAN-16-2379 ID - Zhao2017 ER - TY - JOUR AU - Katt, M. E. AU - Placone, A. L. AU - Wong, A. D. AU - Xu, Z. S. AU - Searson, P. C. PY - 2016 DA - 2016// TI - In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform JO - Front Bioeng Biotechnol VL - 4 UR - https://doi.org/10.3389/fbioe.2016.00012 DO - 10.3389/fbioe.2016.00012 ID - Katt2016 ER - TY - JOUR AU - Sato, T. AU - Stange, D. E. AU - Ferrante, M. AU - Vries, R. G. J. AU - Es, J. H. AU - Brink, S. PY - 2011 DA - 2011// TI - Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium JO - Gastroenterology. VL - 141 UR - https://doi.org/10.1053/j.gastro.2011.07.050 DO - 10.1053/j.gastro.2011.07.050 ID - Sato2011 ER - TY - JOUR AU - Weiswald, L. -. B. AU - Bellet, D. AU - Dangles-Marie, V. PY - 2015 DA - 2015// TI - Spherical cancer models in tumor biology JO - Neoplasia. VL - 17 UR - https://doi.org/10.1016/j.neo.2014.12.004 DO - 10.1016/j.neo.2014.12.004 ID - Weiswald2015 ER - TY - JOUR AU - Clevers, H. PY - 2016 DA - 2016// TI - Modeling development and disease with organoids JO - Cell. VL - 165 UR - https://doi.org/10.1016/j.cell.2016.05.082 DO - 10.1016/j.cell.2016.05.082 ID - Clevers2016 ER - TY - JOUR AU - Weeber, F. AU - Wetering, M. AU - Hoogstraat, M. AU - Dijkstra, K. K. AU - Krijgsman, O. AU - Kuilman, T. PY - 2015 DA - 2015// TI - Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases JO - Proc Natl Acad Sci VL - 112 UR - https://doi.org/10.1073/pnas.1516689112 DO - 10.1073/pnas.1516689112 ID - Weeber2015 ER - TY - JOUR AU - Árnadóttir, S. S. AU - Maria, J. AU - Philippe, L. AU - Bramsen Jesper, B. AU - Iver, N. AU - Michael, K. PY - 2017 DA - 2017// TI - Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures JO - Mol Oncol VL - 12 UR - https://doi.org/10.1002/1878-0261.12156 DO - 10.1002/1878-0261.12156 ID - Árnadóttir2017 ER - TY - JOUR AU - Molla, A. AU - Couvet, M. AU - Coll, J. -. L. AU - Molla, A. AU - Couvet, M. AU - Coll, J. -. L. PY - 2017 DA - 2017// TI - Unsuccessful mitosis in multicellular tumour spheroids JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.15673 DO - 10.18632/oncotarget.15673 ID - Molla2017 ER - TY - STD TI - Liu Q, Zhang Z, Liu Y, Cui Z, Zhang T, Li Z, et al. Cancer cells growing on perfused 3D collagen model produced higher reactive oxygen species level and were more resistant to cisplatin compared to the 2D model. J Appl Biomater Funct Mater. 2018. https://doi.org/10.1177/2280800018764763. ID - ref15 ER - TY - JOUR AU - Mehta, G. AU - Hsiao, A. Y. AU - Ingram, M. AU - Luker, G. D. AU - Takayama, S. PY - 2012 DA - 2012// TI - Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy JO - J Control Release VL - 164 UR - https://doi.org/10.1016/j.jconrel.2012.04.045 DO - 10.1016/j.jconrel.2012.04.045 ID - Mehta2012 ER - TY - JOUR AU - Jeppesen, M. AU - Hagel, G. AU - Glenthoj, A. AU - Vainer, B. AU - Ibsen, P. AU - Harling, H. PY - 2017 DA - 2017// TI - Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0183074 DO - 10.1371/journal.pone.0183074 ID - Jeppesen2017 ER - TY - STD TI - Herter S, Morra L, Schlenker R, Sulcova J, Fahrni L, Waldhauer I, et al. A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents. Cancer Immunol Immunother. 2017;66(1):129–40. ID - ref18 ER - TY - JOUR AU - Aboulkheyr Es, H. AU - Montazeri, L. AU - Aref, A. R. AU - Vosough, M. AU - Baharvand, H. PY - 2018 DA - 2018// TI - Personalized Cancer medicine: an organoid approach JO - Trends Biotechnol VL - 36 UR - https://doi.org/10.1016/j.tibtech.2017.12.005 DO - 10.1016/j.tibtech.2017.12.005 ID - Aboulkheyr Es2018 ER - TY - JOUR AU - Hirt, C. AU - Papadimitropoulos, A. AU - Mele, V. AU - Muraro, M. G. AU - Mengus, C. AU - Iezzi, G. PY - 2014 DA - 2014// TI - “In vitro” 3D models of tumor-immune system interaction JO - Adv Drug Deliv Rev VL - 79–80 UR - https://doi.org/10.1016/j.addr.2014.05.003 DO - 10.1016/j.addr.2014.05.003 ID - Hirt2014 ER - TY - JOUR AU - Klöss, S. AU - Chambron, N. AU - Gardlowski, T. AU - Weil, S. AU - Koch, J. AU - Esser, R. PY - 2015 DA - 2015// TI - Cetuximab reconstitutes pro-inflammatory cytokine secretions and tumor-infiltrating capabilities of sMICA-inhibited NK cells in HNSCC tumor spheroids JO - Front Immunol VL - 6 UR - https://doi.org/10.3389/fimmu.2015.00543 DO - 10.3389/fimmu.2015.00543 ID - Klöss2015 ER - TY - JOUR AU - Giannattasio, A. AU - Weil, S. AU - Kloess, S. AU - Ansari, N. AU - Stelzer, E. H. K. AU - Cerwenka, A. PY - 2015 DA - 2015// TI - Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1321-y DO - 10.1186/s12885-015-1321-y ID - Giannattasio2015 ER - TY - JOUR AU - Hoogstad-van Evert, J. S. AU - Cany, J. AU - Brand, D. AU - Oudenampsen, M. AU - Brock, R. AU - Torensma, R. PY - 2017 DA - 2017// TI - Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1320630 DO - 10.1080/2162402X.2017.1320630 ID - Hoogstad-van Evert2017 ER - TY - JOUR AU - Lanuza, P. M. AU - Vigueras, A. AU - Olivan, S. AU - Prats, A. C. AU - Costas, S. AU - Llamazares, G. PY - 2018 DA - 2018// TI - Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression JO - Oncoimmunology. VL - 7 UR - https://doi.org/10.1080/2162402X.2017.1395123 DO - 10.1080/2162402X.2017.1395123 ID - Lanuza2018 ER - TY - JOUR AU - Sherman, H. AU - Gitschier, H. J. AU - Rossi, A. E. PY - 2018 DA - 2018// TI - A novel three-dimensional immune oncology model for high-throughput testing of tumoricidal activity JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.00857 DO - 10.3389/fimmu.2018.00857 ID - Sherman2018 ER - TY - JOUR AU - Dangles-Marie, V. AU - Richon, S. AU - Behi, M. E. AU - Echchakir, H. AU - Dorothée, G. AU - Thiery, J. PY - 2003 DA - 2003// TI - A three-dimensional tumor cell defect in activating autologous CTLs is associated with inefficient antigen presentation correlated with heat shock protein-70 down-regulation JO - Cancer Res VL - 63 ID - Dangles-Marie2003 ER - TY - JOUR AU - Hoffmann, T. K. AU - Schirlau, K. AU - Sonkoly, E. AU - Brandau, S. AU - Lang, S. AU - Pivarcsi, A. PY - 2009 DA - 2009// TI - A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24269 DO - 10.1002/ijc.24269 ID - Hoffmann2009 ER - TY - JOUR AU - Chang, C. -. H. AU - Wang, Y. AU - Li, R. AU - Rossi, D. L. AU - Liu, D. AU - Rossi, E. A. PY - 2017 DA - 2017// TI - Combination therapy with bispecific antibodies and PD-1 blockade enhances the antitumor potency of T cells JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-3431 DO - 10.1158/0008-5472.CAN-16-3431 ID - Chang2017 ER - TY - JOUR AU - Koeck, S. AU - Kern, J. AU - Zwierzina, M. AU - Gamerith, G. AU - Lorenz, E. AU - Sopper, S. PY - 2017 DA - 2017// TI - The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3+CD8+ tumor infiltrating lymphocyte subpopulations JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1323617 DO - 10.1080/2162402X.2017.1323617 ID - Koeck2017 ER - TY - STD TI - Zboralski D, Hoehlig K, Eulberg D, Froemming A, Vater A. Increasing tumor-infiltrating T cells through inhibition of CXCL12 with NOX-A12 synergizes with PD-1 blockade. Cancer Immunol Res. 2017;5(11):950–6. ID - ref30 ER - TY - JOUR AU - Deng, J. AU - Wang, E. S. AU - Jenkins, R. W. AU - Li, S. AU - Dries, R. AU - Yates, K. PY - 2018 DA - 2018// TI - CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-17-0915 DO - 10.1158/2159-8290.CD-17-0915 ID - Deng2018 ER - TY - JOUR AU - Jenkins, R. W. AU - Aref, A. R. AU - Lizotte, P. H. AU - Ivanova, E. AU - Stinson, S. AU - Zhou, C. W. PY - 2018 DA - 2018// TI - Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-17-0833 DO - 10.1158/2159-8290.CD-17-0833 ID - Jenkins2018 ER - TY - JOUR AU - Allez, M. AU - Tieng, V. AU - Nakazawa, A. AU - Treton, X. AU - Pacault, V. AU - Dulphy, N. PY - 2007 DA - 2007// TI - CD4+NKG2D+ T cells in Crohn’s disease mediate inflammatory and cytotoxic responses through MICA interactions JO - Gastroenterology. VL - 132 UR - https://doi.org/10.1053/j.gastro.2007.03.025 DO - 10.1053/j.gastro.2007.03.025 ID - Allez2007 ER - TY - JOUR AU - Pietra, G. AU - Romagnani, C. AU - Moretta, L. AU - Mingari, M. C. PY - 2009 DA - 2009// TI - HLA-E and HLA-E-Bound Peptides: Recognition by Subsets of NK and T Cells JO - Curr Pharm Des VL - 15 UR - https://doi.org/10.2174/138161209789105207 DO - 10.2174/138161209789105207 ID - Pietra2009 ER - TY - JOUR AU - Barbarin, A. AU - Cayssials, E. AU - Jacomet, F. AU - Nunez, N. G. AU - Basbous, S. AU - Lefèvre, L. PY - 2017 DA - 2017// TI - Phenotype of NK-like CD8(+) T cells with innate features in humans and their relevance in cancer diseases JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.00316 DO - 10.3389/fimmu.2017.00316 ID - Barbarin2017 ER - TY - JOUR AU - Prajapati, K. AU - Perez, C. AU - Rojas, L. B. P. AU - Burke, B. AU - Guevara-Patino, J. A. PY - 2018 DA - 2018// TI - Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy JO - Cell Mol Immunol VL - 15 UR - https://doi.org/10.1038/cmi.2017.161 DO - 10.1038/cmi.2017.161 ID - Prajapati2018 ER - TY - JOUR AU - Raulet, D. H. PY - 2003 DA - 2003// TI - Roles of the NKG2D immunoreceptor and its ligands JO - Nat Rev Immunol VL - 3 UR - https://doi.org/10.1038/nri1199 DO - 10.1038/nri1199 ID - Raulet2003 ER - TY - JOUR AU - Ogasawara, K. AU - Lanier, L. L. PY - 2005 DA - 2005// TI - NKG2D in NK and T cell-mediated immunity JO - J Clin Immunol VL - 25 UR - https://doi.org/10.1007/s10875-005-8786-4 DO - 10.1007/s10875-005-8786-4 ID - Ogasawara2005 ER - TY - JOUR AU - Gunturi, A. AU - Berg, R. E. AU - Forman, J. PY - 2004 DA - 2004// TI - The role of CD94/NKG2 in innate and adaptive immunity JO - Immunol Res VL - 30 UR - https://doi.org/10.1385/IR:30:1:029 DO - 10.1385/IR:30:1:029 ID - Gunturi2004 ER - TY - JOUR AU - Wieten, L. AU - Mahaweni, N. M. AU - Voorter, C. E. M. AU - Bos, G. M. J. AU - Tilanus, M. G. J. PY - 2014 DA - 2014// TI - Clinical and immunological significance of HLA-E in stem cell transplantation and cancer JO - Tissue Antigens VL - 84 UR - https://doi.org/10.1111/tan.12478 DO - 10.1111/tan.12478 ID - Wieten2014 ER - TY - JOUR AU - McGilvray, R. W. AU - Eagle, R. A. AU - Watson, N. F. S. AU - Al-Attar, A. AU - Ball, G. AU - Jafferji, I. PY - 2009 DA - 2009// TI - NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for Immunoediting JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0991 DO - 10.1158/1078-0432.CCR-09-0991 ID - McGilvray2009 ER - TY - JOUR AU - Shen, Y. AU - Shen, Y. AU - Lu, C. AU - Lu, C. AU - Tian, W. AU - Tian, W. PY - 2012 DA - 2012// TI - Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer JO - Int J Oncol VL - 40 UR - https://doi.org/10.3892/ijo.2011.1315 DO - 10.3892/ijo.2011.1315 ID - Shen2012 ER - TY - JOUR AU - Chirica, M. AU - Bourhis, L. AU - Lehmann-Che, J. AU - Chardiny, V. AU - Bouhidel, F. AU - Foulboeuf, L. PY - 2015 DA - 2015// TI - Phenotypic analysis of T cells infiltrating colon cancers: correlations with oncogenetic status JO - Oncoimmunology. VL - 4 UR - https://doi.org/10.1080/2162402X.2015.1016698 DO - 10.1080/2162402X.2015.1016698 ID - Chirica2015 ER - TY - JOUR AU - Levy, E. M. AU - Bianchini, M. AU - Euw, V. AU - María, E. AU - Barrio, M. M. AU - Bravo, A. I. PY - 2008 DA - 2008// TI - Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer JO - Int J Oncol VL - 32 ID - Levy2008 ER - TY - JOUR AU - Huang, R. AU - Zhang, D. AU - Li, F. AU - Xiao, Z. AU - Wu, M. AU - Shi, D. PY - 2017 DA - 2017// TI - Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells JO - Oncol Lett VL - 13 UR - https://doi.org/10.3892/ol.2017.5891 DO - 10.3892/ol.2017.5891 ID - Huang2017 ER - TY - JOUR AU - Capuano, C. AU - Pighi, C. AU - Molfetta, R. AU - Paolini, R. AU - Battella, S. AU - Palmieri, G. PY - 2017 DA - 2017// TI - Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1290037 DO - 10.1080/2162402X.2017.1290037 ID - Capuano2017 ER - TY - JOUR AU - Zhang, J. AU - Basher, F. AU - Wu, J. D. PY - 2015 DA - 2015// TI - NKG2D ligands in tumor immunity: two sides of a coin JO - Front Immunol VL - 6 ID - Zhang2015 ER - TY - JOUR AU - Andrade, L. F. AU - Tay, R. E. AU - Pan, D. AU - Luoma, A. M. AU - Ito, Y. AU - Badrinath, S. PY - 2018 DA - 2018// TI - Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity JO - Science. VL - 359 UR - https://doi.org/10.1126/science.aao0505 DO - 10.1126/science.aao0505 ID - Andrade2018 ER - TY - JOUR AU - Ruggeri, L. AU - Urbani, E. AU - André, P. AU - Mancusi, A. AU - Tosti, A. AU - Topini, F. PY - 2016 DA - 2016// TI - Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells JO - Haematologica. VL - 101 UR - https://doi.org/10.3324/haematol.2015.135301 DO - 10.3324/haematol.2015.135301 ID - Ruggeri2016 ER - TY - BOOK AU - Dijkstra, K. K. AU - Cattaneo, C. M. AU - Weeber, F. AU - Chalabi, M. AU - Haar, J. PY - 2018 DA - 2018// TI - Fanchi LF, et al PB - Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids CY - Cell ID - Dijkstra2018 ER -